Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

38.96
-0.2700-0.69%
Volume:279
Turnover:10.81K
Market Cap:7.79M
PE:- -
High:38.96
Open:39.22
Low:38.96
Close:39.23
52wk High:43.01
52wk Low:24.96
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.12
T/O Rate:0.14%
Dividend:0.32
Dividend Rate:0.82%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Global Milestones Drive Brain-Computer Interface Closer to Commercial Breakthrough Year; A-Share and Hong Kong Stocks Rally, Sanbo Hospital Surges Over 12%

Deep News
·
Jul 27

China Disabled Persons' Federation Responds to Report: Strengthening Technological Empowerment like Cochlear Implants and Brain-Computer Interfaces

Deep News
·
Jul 27

China Disabled Persons' Federation to Promote Brain-Computer Interfaces and Other Tech-Assisted Applications During the 15th Five-Year Plan Period

Deep News
·
Jul 27

Landmark Breakthrough in Brain-Computer Interfaces: Sanbo Hospital Surges 14%, Healthcare ETF Climbs 3%

Deep News
·
Jul 27

Brain-Computer Interface Stocks Surge as Key Breakthroughs Emerge; Nanjing Panda Gains Over 9%, BrainAurora-B Rises Nearly 8%

Stock News
·
Jul 27

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

TIPRANKS
·
Jul 25

China Achieves Major Brain-Computer Interface Breakthrough; Hong Kong-Listed BCI Stocks Open Higher with BrainAurora Mobile Ltd Up Over 8%

Deep News
·
Jul 24

Hong Kong Stocks: Brain-Computer Interface Concepts Open Higher Following Major Domestic Breakthrough and Policy Support

Stock News
·
Jul 24

Netherlands' Argenx Q2 Net Sales Rise

Reuters
·
Jul 23

Neuralink's Soaring Valuation Ignites the Brain-Computer Interface Sector: A Guide to A-Share Market Leaders Across the Full Industry Chain

Deep News
·
Jul 22

Scholar Rock Holding Price Target Maintained with a $58.00/share by Wedbush

Dow Jones
·
Jul 21

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS
·
Jul 21

Switzerland's Novartis Beats Q2 Sales Estimates on Strong Sales Across Priority Brands

Reuters
·
Jul 21

Sweden's Medcap Q2 Net Sales Rise 16% on Organic Growth and Acquisitions

Reuters
·
Jul 21

Scholar Rock Says EU Opinion on SMA Drug May be Pushed to Later in 2026

Reuters
·
Jul 20

China's Ministry of Industry and Information Technology Aims to Drive Widespread Adoption of Humanoid Robots and Brain-Computer Interfaces

Deep News
·
Jul 20

Scholar Rock provides update on timing of CHMP opinion for apitegromab MAA

TIPRANKS
·
Jul 20

Scholar Rock Announces Press Release on Apitegromab CHMP Opinion Timing for SMA MAA

Reuters
·
Jul 20

Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (chmp) Opinion for Apitegromab Marketing Authorisation Application (maa) for Spinal Muscular Atrophy (sma)

THOMSON REUTERS
·
Jul 20

Scholar Rock Holding Corp - Apitegromab Chmp Opinion Expected After Catalent Indiana Classification or Second Facility Inclusion

THOMSON REUTERS
·
Jul 20